HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Prommegger, R. Articles by Salzer, G. M. Search for Related Content PubMed PubMed Citation Articles by Prommegger, R. Articles by Salzer, G. M.

Ann Thorac Surg 2000;70:1861-1864
© 2000 The Society of Thoracic Surgeons

---

Original article: general thoracic

Neopterin: a prognostic variable in operations for lung cancer

^a Department of Thoracic Surgery, University of Innsbruck, Innsbruck, Austria
^b Institute of Medical Chemistry and Biochemistry, University of Innsbruck, Innsbruck, Austria

Accepted for publication April 27, 2000.

Address reprint requests to Dr Prommegger, Department of Thoracic Surgery, University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria
e-mail: rupert.prommegger{at}uibk.ac.at

Background. We studied the prognostic value of preoperatively measured neopterin to predict survival of lung cancer patients. Neopterin is produced and secreted by interferon--stimulated monocytic cells. High urinary neopterin concentrations are found in patients with viral infections, allograft rejection episodes, and some malignant diseases. In various tumor types high urinary neopterin concentrations are associated with a worse prognosis.

Methods. Preoperative neopterin levels of 110 patients (29 women, 81 men) with lung cancer including 7 patients with small cell lung cancer were measured and related to the time of survival after operation. Patients with clinically suspected stage IIIB lung cancer were not operated and therefore not enrolled in this study. Infectious diseases were not apparent at the time of preoperative urine sampling. Median postoperative follow-up period was 17.4 months.

Results. In a univariate analysis, patients with a preoperative neopterin concentration of more than 212 µmol/mol creatinine (4th quartile) were determined to have a significantly lower survival probability. In a multivariate analysis, a neopterin concentration of more than 212 µmol/mol creatinine (p < 0.01) and T-stage status (p < 0.005) were determined to be significantly predictive variables for worse survival prognosis.

Conclusions. Preoperative neopterin proved to be a reliable prognostic factor for survival. Immunology may provide an accurate assessment of tumor aggression and its clinical behavior. In this sense, neopterin can serve as an immunologically based estimation of malignant outgrowth. In patients who are operable by clinical tumor stage but have a high risk for operation, elevated preoperative neopterin may help in the decision for a nonoperative treatment.

This article has been cited by other articles:

				K. Schroecksnadel, F. Ueberall, and D. Fuchs Telomere Length Abnormalities and Human Cancer Clin. Cancer Res., January 15, 2005; 11(2): 860 - 860. [Full Text] [PDF]

				M. D. Brundage, D. Davies, and W. J. Mackillop Prognostic Factors in Non-small Cell Lung Cancer* : A Decade of Progress Chest, September 1, 2002; 122(3): 1037 - 1057. [Abstract] [Full Text] [PDF]